 |
市場調査レポート
商品コード
1373854
メンブレンクロマトグラフィの世界市場 (2023-2030年)：タイプ (消耗品・付属品)・用途 (製薬&バイオ医薬品企業・CRO&学術研究機関) 別の規模・シェア・成長分析・予測Global Membrane Chromatography Market Size, Share, Growth Analysis, By Type(Consumables and accessories ), By Application(Pharmaceutical and biopharmaceutical companies, CROs and Academic and research institutes) - Industry Forecast 2023-2030 |
||||||
| メンブレンクロマトグラフィの世界市場 (2023-2030年)：タイプ (消耗品・付属品)・用途 (製薬&バイオ医薬品企業・CRO&学術研究機関) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のメンブレンクロマトグラフィの市場規模は、2021年の1億9,000万米ドルと評価され、2022年の2億2,000万米ドルから、予測期間中は14.9%のCAGRで推移し、2030年には6億7,000万米ドルの規模に成長すると予測されています。
メンブレンクロマトグラフィの市場は、バイオ医薬品業界の中でも急速に成長している分野です。メンブレンクロマトグラフィは、高効率、精製性能の向上、プロセス時間の短縮など、従来のクロマトグラフィー法に比べて大きな利点を提供する新しい技術であり、タンパク質、抗体、ウイルスなど、さまざまな生体分子を効率的に分離・精製し、生産性とコスト効率を高めることができるため、非常に高い人気があります。同市場は、バイオ医薬品需要の増加、R&D投資の増加、膜技術の進歩といった要因によって大きく成長しています。また、癌、自己免疫疾患、感染症などの慢性疾患の拡大が、標的療法や生物製剤の需要を押し上げ、メンブレンクロマトグラフィ技術の採用を後押ししています。さらに、厳格な規制ガイドラインの導入と高品質の精製プロセスへのニーズも、市場成長をさらに後押ししています。 地域別では、確立されたバイオ医薬品産業の存在、強固な研究インフラ、政府の積極的な取り組みにより、北米が市場を独占しています。一方で、アジア太平洋地域も、ヘルスケアインフラへの投資の増加、アウトソーシング活動の活発化、バイオ医薬品部門の成長に牽引され、今後数年間で大きな成長の可能性を示すと予想されています。
世界のメンブレンクロマトグラフィ市場の主要動向としては、シングルユース技術の普及があります。シングルユースのメンブレンクロマトグラフィシステムには、クロスコンタミネーションのリスク低減、運用の柔軟性向上、洗浄とバリデーション手順の合理化など、さまざまなメリットがあります。また、シングルユースシステムは、水とエネルギーの消費を削減する役割を果たし、環境的に持続可能な選択肢となります。
当レポートでは、世界のメンブレンクロマトグラフィの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界のメンブレンクロマトグラフィ市場：タイプ別
- 市場概要
- 消耗品
- 付属品
- 世界のメンブレンクロマトグラフィ市場：用途別
- 市場概要
- 製薬およびバイオ医薬品企業
- CROおよび学術研究機関
- 世界のメンブレンクロマトグラフィ市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- 3M
- Thermo Fisher Scientific
- Merck KGaA
- Danaher Corporation
- Sartorius AG
- GE Healthcare
- Repligen Corporation
- Pall Corporation
- Novasep Holding S.A.S
- Asahi Kasei Corporation
- EMD Millipore Corporation
- Parker Hannifin Corporation
- Membrane Solutions
- Tosoh Corporation
- Agilent Technologies
- Purilogics
- Membranology
- Axiva Sichem Biotech
- AppliTek
- Phenomenex
Global Membrane Chromatography Market size was valued at USD 0.19 billion in 2021 and is poised to grow from USD 0.22 billion in 2022 to USD 0.67 billion by 2030, growing at a CAGR of 14.9% during the forecast period (2023-2030).
The Global Membrane Chromatography Market is a rapidly growing sector within the biopharmaceutical industry. Membrane chromatography is a novel technique that offers significant advantages over traditional chromatography methods, such as high efficiency, improved purification performance, and reduced process time. This technology has gained immense popularity due to its ability to effectively separate and purify various biomolecules, including proteins, antibodies, and viruses, with enhanced productivity and cost-effectiveness. The market is witnessing substantial growth driven by factors such as increasing demand for biopharmaceuticals, rising R&D investments, and advancements in membrane technology. Additionally, the growing prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, has propelled the demand for targeted therapies and biologics, thereby boosting the adoption of membrane chromatography techniques. Moreover, the implementation of stringent regulatory guidelines and the need for high-quality purification processes have further fueled the market growth. Geographically, North America dominated the market due to the presence of a well-established biopharmaceutical industry, robust research infrastructure, and favorable government initiatives. However, the Asia Pacific region is expected to exhibit significant growth potential in the coming years, driven by increasing investments in healthcare infrastructure, rising outsourcing activities, and a growing biopharmaceutical sector. Key market players are actively engaged in research and development activities to introduce innovative membrane chromatography products and expand their market presence.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Membrane Chromatography Market Segmental Analysis
Global Membrane Chromatography Market is segmented by type, application, and region. Based on type, the market can be segmented into Consumables and accessories. Based on application, the market is segmented into Pharmaceutical and biopharmaceutical companies, CROs and Academic and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Membrane Chromatography Market Dynamics
Drivers of the Global Membrane Chromatography Market
Increasing demand for biopharmaceuticals
One key driver of the Global Membrane Chromatography Market is the increasing demand for biopharmaceuticals. Biopharmaceuticals, including proteins, antibodies, and vaccines, are gaining popularity for their effectiveness in treating various diseases. Membrane chromatography offers efficient purification and separation of these biomolecules, driving its adoption in the biopharmaceutical industry.
Restraints in the Global Membrane Chromatography Market
High cost of membrane chromatography systems and consumables
One key restraint of the market is the high cost of membrane chromatography systems and consumables. The initial investment required for setting up membrane chromatography processes can be significant, which can pose a challenge, especially for smaller biopharmaceutical companies or research institutes with limited budgets. The cost of consumables, such as membranes and columns, can also add up over time. The high cost of implementation and ongoing expenses associated with membrane chromatography can act as a restraint to market growth, particularly in cost-sensitive regions or organizations.
Trends in the Global Membrane Chromatography Market
A prominent market trend in the Global Membrane Chromatography Market involves the growing acceptance of single-use technologies. These single-use membrane chromatography systems come with several benefits, notably decreased risks of cross-contamination, enhanced operational flexibility, and streamlined cleaning and validation procedures. The shift towards adopting single-use technologies is primarily motivated by the pursuit of cost-effective and efficient biopharmaceutical manufacturing processes, along with the increasing market demand for personalized and precisely targeted therapies. Furthermore, these single-use systems play a role in diminishing water and energy consumption, rendering them environmentally sustainable choices.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Membrane Chromatography Market by Type
- Market Overview
- Consumables and accessories
- Global Membrane Chromatography Market by Application
- Market Overview
- Pharmaceutical and biopharmaceutical companies
- CROs and Academic and research institutes
- Global Membrane Chromatography Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- 3M (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Repligen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pall Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novasep Holding S.A.S (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Asahi Kasei Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EMD Millipore Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Parker Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Membrane Solutions (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tosoh Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Purilogics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Membranology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Axiva Sichem Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AppliTek (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Phenomenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
